papaverine has been researched along with diatrizoic acid in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Amplatz, K; Korbuly, D; Moore, R; Ovitt, TW; Payne, TJ; Scheibel, RL; Tuna, N | 1 |
| White, CW; Wilson, RF | 1 |
| Hodgson, JM; Williams, DO | 1 |
| Abraham, J; Chandra, R | 1 |
| Burbridge, BE | 1 |
| LEMMEN, LJ; REIGH, EE | 1 |
1 review(s) available for papaverine and diatrizoic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for papaverine and diatrizoic acid
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Regional Myocardial Blood Flow Measurement in the Evaluation of Patients with Coronary Artery Disease.
Topics: Contrast Media; Coronary Circulation; Coronary Disease; Diatrizoate; Humans; Papaverine; Radionuclide Imaging; Vasodilator Agents; Xenon Radioisotopes | 1975 |
Measurement of maximal coronary flow reserve: a technique for assessing the physiologic significance of coronary arterial lesions in humans.
Topics: Animals; Blood Flow Velocity; Cardiac Catheterization; Cattle; Coronary Circulation; Coronary Disease; Coronary Vessels; Diatrizoate; Diatrizoate Meglumine; Dipyridamole; Drug Combinations; Echocardiography; Humans; Papaverine; Vasodilation | 1987 |
Superiority of intracoronary papaverine to radiographic contrast for measuring coronary flow reserve in patients with ischemic heart disease.
Topics: Blood Flow Velocity; Cardiac Catheterization; Cineradiography; Contrast Media; Coronary Angiography; Coronary Circulation; Coronary Disease; Diatrizoate; Diatrizoate Meglumine; Drug Combinations; Drug Evaluation; Humans; Hyperemia; Papaverine; Retrospective Studies | 1987 |
Modification of neurotoxicity of methylglucamine diatrizoate (hypaque 75 per cent) by intra-arterial instillation of vasoactive drugs.
Topics: Animals; Central Nervous System Diseases; Cerebral Angiography; Diatrizoate; Haplorhini; Injections, Intra-Arterial; Norepinephrine; Papaverine | 1969 |
Incompatibility of papaverine with various intravascular contrast agents.
Topics: Blood; Chemical Precipitation; Contrast Media; Diatrizoate; Diatrizoate Meglumine; Drug Incompatibility; Humans; In Vitro Techniques; Iopamidol; Ioxaglic Acid; Papaverine | 1993 |
Sodium diacetrizoate (hypaque sodium) in cerebral angiography. III. Study of intracarotid injection of papaverine.
Topics: Brain; Cardiovascular System; Cerebral Angiography; Diatrizoate; Injections; Papaverine; Sodium; Sodium, Dietary | 1959 |